Get a free sample of Dermal Toxicity Testing Market
Thank you!
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Dermal Toxicity Testing Market
Thank you!
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Dermal Toxicity Testing Market Size
Dermal Toxicity Testing Market size was valued at USD 2.1 billion in 2022 and is anticipated to grow at a CAGR of around 8.3% between 2023 and 2032. Dermal toxicity testing is a type of safety assessment conducted to evaluate the potential harmful effects of a substance when it comes into contact with the skin.
The goal of dermal toxicity testing is to determine the adverse effects a substance may have on the skin, including irritation, sensitization, and other forms of damage. As per Allergy and Asthma Network Organization of U.S., currently more than 50 million Americans are suffering from one or other kind of allergy. Such rising number of allergy cases is said to increase the demand for dermal toxicity testing.
Additionally, there is a growing recognition of the ethical concerns associated with the use of animals in testing procedures. Several organizations advocate for the reduction and replacement of animal testing due to concerns about the welfare and treatment of animals. Such aforementioned factors will boost industry growth during forecast period.
Why is in-vitro testing method gaining traction in the dermal toxicity testing industry?
The in-vitro testing segment had a market share of over 42% in 2022 and will grow through 2032 due to advancements in cell culture technologies that have improved the reliability and relevance of in-vitro models.
How big is the dermal toxicity testing market?
The dermal toxicity testing industry was valued at USD 2.1 billion in 2022 and is estimated to reach USD 4.5 billion by 2032 as there is a growing recognition of the ethical concerns associated with the use of animals in testing procedures.
Who are the key players in the global dermal toxicity testing industry?
QIMA LTD, Charles River Laboratories, Evotec, MatTek Corporation, Eurofins Scientific, SGS Group, Intertek Group, InVivo Biosystems, Eurofins Scientific, and Qiagen N.V.
What are the factors influencing the U.S. dermal toxicity testing industry?
U.S. dermal toxicity testing market accounted for over USD 1.9 billion in 2022 and is predicted to witness substantial growth through 2032 owing to an increased emphasis on alternatives to traditional animal testing methods.